4.4 Review

Wnt/β-catenin signaling in bone marrow niche

期刊

CELL AND TISSUE RESEARCH
卷 363, 期 2, 页码 321-335

出版社

SPRINGER
DOI: 10.1007/s00441-015-2300-y

关键词

Bonemarrowniche; Wnt/beta-catenin; Osteoblast; Osteoclast; Cellular senescence

向作者/读者索取更多资源

The bone marrow (BM) niche is a specific physiological environment for hematopoietic and non-hematopoietic stem cells (HSCs). Several signaling pathways (including Wnt/beta-catenin) regulate various aspects of stem cell growth, function and death in the BM niche. In addition, the canonical Wnt pathway is crucial for directing self-renewal and differentiation as important mechanisms in many types of stem cells. We review the role of the Wnt/beta-catenin pathway in the BM niche and its importance in stem cells. Relevant literature was identified by a PubMed search (1997-2014) of English-language literature by using the following keywords: BM niche, Wnt/beta-catenin signaling, osteoblast, osteoclast and bone disease. The Wnt/beta-catenin pathway regulates the stability of the beta-catenin proto-oncogene. The stabilized beta-catenin then translocates to the nucleus, forming a beta-catenin-TCF/LEF complex regulating the transcription of specific target genes. Stem cells require beta-catenin to mediate their response to Wnt signaling for maintenance and transition from the pluripotent state during embryogenesis. In adult stem cells, Wnt signaling functions at various hierarchical levels to contribute to the specification of the diverse tissues. Aberrant Wnt/beta-catenin signaling and its downstream transcriptional regulators are observed in several malignant stem cells and human cancers. Because Wnt signaling can maintain stem cells and cancer cells, the ability to modulate the Wnt pathway either positively or negatively may be of therapeutic relevance. The controlled activation of Wnt signaling might allow us to enhance stem and progenitor cell activity when regeneration is needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases

Narges Ansari, Sahar Najafi, Saied Shahrabi, Najmaldin Saki

Summary: PEAR1, a platelet receptor, is crucial for hemostasis by mediating platelet adhesion and aggregation. Dysfunctional PEAR1 can disrupt platelet aggregation in CVDs patients. Studies suggest that PEAR1 polymorphisms could affect homeostasis and the function of cardiac drugs, indicating potential implications for patient treatment.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Oncology

Chemo/radiotherapy-Induced Bone Marrow Niche Alterations

Hassan Rafieemehr, Masumeh Maleki Behzad, Saeed Azandeh, Niloofar Farshchi, Mohammad Ghasemi Dehcheshmeh, Najmaldin Saki

Summary: The BM niche is a specific microenvironment for HSCs and non-hematopoietic cells, and evidence suggests that chemo/radiotherapy can disrupt the balance within the marrow cavity, leading to bone loss, abnormal hematopoiesis, and enhanced differentiation potential of mesenchymal stem cells towards adipogenesis. Understanding the mechanisms behind these changes may help in the development of therapeutic interventions to prevent BM niche defects.

CANCER INVESTIGATION (2021)

Review Cell Biology

The effect of inflammatory factors and their inhibitors on the hematopoietic stem cells fate

Sahar Najafi, Majid Ghanavat, Saied Shahrabi, Zahra Gatavizadeh, Najmaldin Saki

Summary: Inflammatory cytokines play a critical role in the differentiation of HSCs, stimulating or inhibiting hematopoietic progenitors to combat inflammation and leukemic conditions.

CELL BIOLOGY INTERNATIONAL (2021)

Review Biochemistry & Molecular Biology

Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches

Habib Hybar, Najmaldin Saki, Mohsen Maleknia, Mana Moghaddasi, Armin Bordbar, Maliheh Naghavi

Summary: AERD is characterized by immune cells dysfunction, with ILC-2 playing a significant role in disease progression by producing cytokines that induce allergic reactions and activate mast cells and basophils, ultimately exacerbating the condition. Monoclonal antibody therapy and Aspirin desensitization have been identified as potential treatment strategies for prevention and management.

MOLECULAR BIOLOGY REPORTS (2021)

Review Cell Biology

Aplastic anemia, cellular and molecular aspects

Mohammad R. Javan, Najmaldin Saki, Bahareh Moghimian-Boroujeni

Summary: Aplastic anemia is an autoimmune disorder characterized by bone marrow and peripheral blood pancytopenia, with the pathogenesis remaining unclear. The disease involves impairment of both hematopoietic stem cells and mesenchymal stromal cells, leading to changes in T lymphocyte ratio and disease progression. The most common mechanism of AA is damage by the immune system, causing increased apoptosis in progenitor cells.

CELL BIOLOGY INTERNATIONAL (2021)

Article Microbiology

Transcription Factors of CAT1, EFG1, and BCR1 Are Effective in Persister Cells of Candida albicans-Associated HIV-Positive and Chemotherapy Patients

Elham Aboualigalehdari, Maryam Tahmasebi Birgani, Mahnaz Fatahinia, Mehran Hosseinzadeh

Summary: The study found that BCR1, CAT1, and EFG1 genes were significantly higher expressed in persister isolates of Candida albicans producing biofilms compared to non-persister isolates. The most crucial factor in the production of persister cells was identified to be biofilm binding and production, rather than biofilm development. Catalase also played an essential role in the production of persister cells in C. albicans biofilm producers by detoxifying ROS.

FRONTIERS IN MICROBIOLOGY (2021)

Article Oncology

Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation

Mahdiyar Iravani Saadi, Mani Ramzi, Mehran Hosseinzadeh, Narjes Ebrahimi, Maryam Owjfard, Ehsan Nabi Abdolyousefi, Zahra Hesami, Behnaz Valibeigi, Neda Zareei, Fataneh Tavasolian, Hourvash Haghighinejad, Abdolhossein Zare

Summary: This study evaluated the expression levels of IL-6 and IL-18 in AML patients and found that the expression levels of these cytokines were associated with treatment response and GvHD. Higher levels of IL-6 and IL-18 were observed in patients without response to treatment or experiencing aGvHD after bone marrow transplantation.

INDIAN JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Mathematical & Computational Biology

Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of β-Thalassemia Trait from Iron Deficiency Anemia

Mina Jahangiri, Fakher Rahim, Najmaldin Saki, Amal Saki Malehi

Summary: This study introduces a Bayesian tree-based method for differentiating between beta-thalassemia trait and iron deficiency anemia. The models propose automatic detection of beta-thalassemia carriers, with mean corpuscular volume being the main predictor in diagnostic discrimination. CART showed higher sensitivity and negative predictive value compared to BLTREED, but with a higher false-positive rate. The BLTREED model demonstrated better performance in terms of area under the curve.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)

Review Oncology

Association of human papillomavirus with breast cancer: a new perspective on an old debate

Daryush Purrahman, Arshid Yousefi Avarvand, Agnieszka Paradowska-Gorycka, Najmaldin Saki, Hossein Karimpourian, Hossein Jodat, Mohammad-Reza Mahmoudian-Sani

Summary: Breast cancer is a common cancer among women, and its exact cause is still unknown. The association between human papillomavirus (HPV) and breast cancer has been explored in numerous studies, but contradictory results have been obtained. This review examines the existing evidence and hypotheses about the association between HPV infection and breast cancer, as well as the potential mechanisms involved.

FUTURE ONCOLOGY (2022)

Article Pharmacology & Pharmacy

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients

Reza Safaei Nodehi, Behjat Kalantari, Jahangir Raafat, Nafiseh Ansarinejad, Vahid Moazed, Seyed Mohammad Reza Mortazavizadeh, Mehran Hosseinzadeh, Bayazid Ghaderi, Arash Jenabian, Mojtaba Qadyani, Shirin Haghighat, Abolghasem Allahyari, Mehrzad Mirzania, Mohammad Seghatoleslami, Mehrdad Payandeh, Afsaneh Alikhasi, Hamidreza Kafi, Farhad Shahi

Summary: This study compared the efficacy and safety of TA4415V, a trastuzumab biosimilar, with reference trastuzumab in Iranian patients with early-stage breast cancer. The results showed no significant difference in pathologic complete response rate, overall response rate, and breast-conserving surgery rate between TA4415V and reference trastuzumab. The safety profile and immunogenicity were also comparable.

BMC PHARMACOLOGY & TOXICOLOGY (2022)

Article Oncology

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

Abolghasem Allahyari, Ali Ehsanpour, Nafiseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kafi, Safa Najafi

Summary: This study compared the efficacy and safety of a proposed pertuzumab biosimilar with the reference pertuzumab in HER2-positive breast cancer patients. The results showed that the proposed biosimilar was equivalent in efficacy and safety to the reference product, which is clinically significant for the treatment of breast cancer patients.

BMC CANCER (2022)

Review Virology

Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis

Alireza Mohebbi, Habib Haybar, Fatemeh Nakhaei Moghaddam, Zahra Rasti, Mohammad Amin Vahid, Najmaldin Saki

Summary: This study found that COVID-19 patients had endothelial dysfunction and elevated levels of endothelial biomarkers. Patients with poor outcome had higher levels of von Willebrand factor, Ang-2, E-selectin, P-selectin, syndecan-1, MR-proADM, vascular endothelial growth factor, sFLT-1, and lower levels of ADAMTS13 compared to patients with good outcome.

REVIEWS IN MEDICAL VIROLOGY (2023)

Article Pediatrics

rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura

Fatemeh Zeylabi, Mohammad Taha Jalali, Gholam-Abbas Kaydani, Kaveh Jaseb, Najmaldin Saki

Summary: Immune thrombocytopenic purpura (ITP) is an immune bleeding disorder associated with genetic factors and interleukin-10 (IL-10) rs1800890 polymorphism. This study found that individuals with the AA genotype were less likely to develop ITP, while the AT genotype was more common in ITP patients. However, there was no significant association between rs1800890 genotypes in the acute and chronic groups. Additionally, women had a higher frequency of this polymorphism and the rs1800890 AA genotype was associated with higher platelet counts.

JOURNAL OF PEDIATRIC GENETICS (2023)

Review Genetics & Heredity

lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases

Habib Haybar, Narjes Sadat Sadati, Daryush Purrahman, Mohammad Reza Mahmoudian-Sani, Najmaldin Saki

Summary: Cardiovascular diseases (CVDs) are major causes of death worldwide. Understanding the molecular mechanisms and signaling pathways involved in CVD pathogenesis is crucial for the development of accurate diagnostic techniques, effective prognostic markers, and potential therapeutic targets. Recent research suggests that the lncRNA TUG1 can serve as a biomarker for predicting the prognosis of CVD.

EPIGENOMICS (2023)

暂无数据